Chemed Corporation $CHE Position Lifted by Signal Advisors Wealth LLC

Signal Advisors Wealth LLC grew its stake in shares of Chemed Corporation (NYSE:CHE) by 82.2% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 17,466 shares of the company’s stock after acquiring an additional 7,880 shares during the period. Signal Advisors Wealth LLC owned about 0.12% of Chemed worth $7,820,000 at the end of the most recent quarter.

Other institutional investors have also modified their holdings of the company. Kayne Anderson Rudnick Investment Management LLC lifted its position in shares of Chemed by 2.6% during the first quarter. Kayne Anderson Rudnick Investment Management LLC now owns 597,175 shares of the company’s stock worth $367,454,000 after purchasing an additional 15,041 shares during the last quarter. Acadian Asset Management LLC lifted its holdings in Chemed by 69.3% during the 2nd quarter. Acadian Asset Management LLC now owns 250,722 shares of the company’s stock worth $122,056,000 after buying an additional 102,597 shares during the last quarter. Boston Trust Walden Corp grew its position in shares of Chemed by 0.4% in the 2nd quarter. Boston Trust Walden Corp now owns 247,434 shares of the company’s stock worth $120,483,000 after acquiring an additional 1,083 shares in the last quarter. Dimensional Fund Advisors LP increased its holdings in shares of Chemed by 9.7% in the 1st quarter. Dimensional Fund Advisors LP now owns 218,675 shares of the company’s stock valued at $134,547,000 after acquiring an additional 19,421 shares during the last quarter. Finally, Northern Trust Corp raised its position in shares of Chemed by 3.4% during the 1st quarter. Northern Trust Corp now owns 215,523 shares of the company’s stock valued at $132,616,000 after acquiring an additional 6,988 shares in the last quarter. Institutional investors and hedge funds own 95.85% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have commented on CHE. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Chemed in a report on Wednesday, October 8th. Bank of America decreased their price target on shares of Chemed from $610.00 to $595.00 and set a “buy” rating for the company in a report on Wednesday, September 10th. Jefferies Financial Group upgraded shares of Chemed from a “hold” rating to a “buy” rating and increased their price objective for the stock from $490.00 to $550.00 in a research note on Tuesday, September 2nd. Zacks Research upgraded Chemed from a “strong sell” rating to a “hold” rating in a research note on Thursday, October 30th. Finally, Royal Bank Of Canada lowered their target price on Chemed from $589.00 to $572.00 and set an “outperform” rating for the company in a report on Monday, November 10th. Four equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $574.25.

Insiders Place Their Bets

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the business’s stock in a transaction on Monday, November 24th. The stock was sold at an average price of $437.55, for a total transaction of $875,100.00. Following the completion of the transaction, the chief executive officer owned 94,197 shares in the company, valued at approximately $41,215,897.35. The trade was a 2.08% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 3.29% of the stock is owned by insiders.

Chemed Stock Up 1.2%

Shares of NYSE:CHE opened at $435.26 on Friday. The company’s 50-day moving average price is $435.57 and its 200 day moving average price is $459.77. The company has a market cap of $6.16 billion, a PE ratio of 23.02, a P/E/G ratio of 2.40 and a beta of 0.46. Chemed Corporation has a fifty-two week low of $408.42 and a fifty-two week high of $623.60.

Chemed (NYSE:CHE) last posted its earnings results on Tuesday, October 28th. The company reported $5.27 EPS for the quarter, missing the consensus estimate of $5.39 by ($0.12). Chemed had a return on equity of 25.89% and a net margin of 11.02%.The firm had revenue of $624.90 million during the quarter, compared to the consensus estimate of $626.04 million. During the same quarter last year, the company posted $5.64 EPS. Chemed’s revenue for the quarter was up 3.1% on a year-over-year basis. Chemed has set its FY 2025 guidance at 22.000-22.300 EPS. As a group, equities analysts anticipate that Chemed Corporation will post 21.43 EPS for the current year.

Chemed Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, December 5th. Investors of record on Monday, November 17th were given a $0.60 dividend. This represents a $2.40 annualized dividend and a yield of 0.6%. The ex-dividend date was Monday, November 17th. Chemed’s dividend payout ratio (DPR) is currently 12.69%.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.